🔗 Permalink

Inventor profile of:

Gordon Freeman

City:

Brookline, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-03-20

Top Assignees for applications by Gordon Freeman

The entities that hold a legal rights for patent applications filed by inventor Freeman Gordon:

Dana-Farber-Cancer Institute, Inc. 17 Boston, MA United States
Emory University 10 Atlanta, GA United States
President and Fellows of Harvard College 7 Cambridge, MA United States
Brigham and Women's Hospital 4 Boston, MA United States
BRIGHAM AND WOMEN'S HOSPITAL, INC. 3 Boston, MA United States
GENETICS INSTITUTE, LLC 2 Cambridge, MA United States
Dana-Faber Cancer Institute, Inc. 1 Boston, MA United States

Recent patent applications by Freeman Gordon

Gordon Freeman from Brookline, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-20

US20250092114A1

Chemistry; metallurgy

NKG2D-FC FOR IMMUNOTHERAPY

#2 | 2022-01-06

US20220002382A1

Chemistry; metallurgy

NKG2D-FC FOR IMMUNOTHERAPY

#3 | 2020-07-16

US20200223926A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#4 | 2019-10-10

US20190309065A1

Chemistry; metallurgy

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#5 | 2019-01-31

US20190031758A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#6 | 2018-06-07

US20180155430A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#7 | 2017-05-25

US20170146520A1

Physics

METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#8 | 2016-12-15

US20160362492A1

Chemistry; metallurgy

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#9 | 2015-08-27

US20150239972A1

Chemistry; metallurgy

METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#10 | 2014-06-26

US20140178370A1

Human necessities

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#11 | 2012-10-04

US20120251537A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#12 | 2011-12-22

US20110311535A1

Chemistry; metallurgy

NKG2D-fc for immunotherapy

#13 | 2010-06-17

US20100151492A1

Physics

Methods for the treatment of infections and tumors

#14 | 2010-02-18

US20100040614A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#15 | 2008-10-07

US9895837

Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal

#16 | 2008-05-22

US20080118511A1

Physics

Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1

#17 | 2007-05-31

US20070122378A1

Chemistry; metallurgy

Methods and compositions for the treatment of persistent infections

#18 | 2006-07-13

US20060153841A1

Human necessities

B7-4 Antibodies and uses therefor

#19 | 2006-05-02

US10002775

B7-4 polypeptides and uses therefor

#20 | 2005-08-30

US9644934

Nucleic acids encoding costimulatory molecule B7-4

InventorID:

814412 ⎘